跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ABIRATERONA FRESENIUS KABI 250 MG COMPRIMIDOS EFG
Approved
STANDARD
ABIRATERONA FRESENIUS KABI 250 MG COMPRIMIDOS EFG
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 25, 2021
Approval ID
d993c0c1ede789db
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
d993c0c1ede789db
Drug Cima Aemps Name
ABIRATERONA FRESENIUS KABI 250 MG COMPRIMIDOS EFG
Register Number
86049
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2021-06-25
Dosage Form
COMPRIMIDO
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
ABIRATERONA ACETATO
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 25, 2021
Approval ID
d993c0c1ede789db
Type
Standard
Back to CIMA-AEMPS Approvals
ABIRATERONA FRESENIUS KABI 250 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
